Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002027273 | SCV002308986 | uncertain significance | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | 2023-08-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PIGA protein function. ClinVar contains an entry for this variant (Variation ID: 1517329). This variant has not been reported in the literature in individuals affected with PIGA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 79 of the PIGA protein (p.Gly79Asp). |
Mayo Clinic Laboratories, |
RCV002246659 | SCV002520075 | likely pathogenic | not provided | 2021-06-16 | criteria provided, single submitter | clinical testing | PM2, PM1, PM5 |